Authorization

More than 150 Companies Adopt Veeva Vault RIM Applications to Streamline Regulatory Processes

DIA Regulatory Submissions, Information, and Document Management
(RSIDM) Forum--
Veeva
Systems (NYSE:VEEV) today announced increasing numbers of life
sciences companies are adopting applications in Veeva
Vault RIM, the first unified suite of RIM applications on one cloud
platform, to modernize their regulatory processes and systems. More than
150 companies are implementing Vault RIM applications, including four of
the top 10 largest global pharmaceutical companies, to streamline
submission development and provide greater visibility across end-to-end
processes.


Vault RIM brings together regulatory content and data on a single
platform so teams have one authoritative source for submission
documents, published dossiers, health authority interactions, and
product registrations. With Vault RIM, life sciences companies can
eliminate the need for multiple systems and manual tracking that slow
execution and increase compliance risk.


The latest addition to the Vault RIM suite of applications, Veeva
Vault Submissions Publishing, is a new approach that brings together
publishing activities with document planning, authoring, and approval in
a single system to streamline the entire submission development process.
This enables customers to significantly speed regulatory submission
preparation and delivery. Melinta Therapeutics, for example, cut its
submission development time in half and published 100 submissions within
the first two months of using Vault Submissions Publishing.


Vault Submissions Publishing enables a continuous publishing process to
finish publishing steps sooner so validation issues are identified and
fixed faster for greater efficiency and improved compliance. Continuous
publishing eliminates the manual movement of documents between multiple
systems and reduces the number of document transfers to one a?? when the
dossier is transmitted directly to the health authority.


"With a continuous publishing model, regulatory teams can identify any
errors and address broken links to source data as the submission is
being built so teams dona??t have to go through the lengthy republishing
process over and over,a?? said Shelly Plapp, director of regulatory
operations at Melinta. "By the time you are ready to publish, the
submission is already quality checked and correct.a??
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2019    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
25262728